L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea
· Delayed Price · Currency is KRW 82,000
-6,100 (-6.92%)
Mar 9, 2026, 3:30 PM KST
L&C BIO Co.,LTD Revenue
L&C BIO Co.,LTD had revenue of 22.56B KRW in the quarter ending September 30, 2025, with 21.66% growth. This brings the company's revenue in the last twelve months to 79.99B, up 19.41% year-over-year. In the year 2024, L&C BIO Co.,LTD had annual revenue of 72.09B with 9.35% growth.
Revenue (ttm)
79.99B
Revenue Growth
+19.41%
P/S Ratio
25.47
Revenue / Employee
567.32M
Employees
141
Market Cap
2,037.05B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Seers Technology Co., LTD. | 11.42B |
| Seegene | 458.94B |
| Curexo | 27.85B |
| WON TECH | 147.26B |
| i-SENS | 313.10B |
| ToolGen | 1.07B |
| InBody Co.,Ltd | 226.62B |
| Bio Plus | 96.80B |